11/01/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

11/01/2025

Jan 11, 2025, 10:05 | Blog
Rémy Duléry: T cell malignancies after CAR T cell therapy in the DESCAR-T registry
Rémy Duléry, Professor of Hematology at Sorbonne University, Saint-Antoine Hospital in Paris, shared on X:…
Jan 11, 2025, 09:45 | Blog
Jarushka Naidoo: Beaumont Hospital Unveils New 5-Year Strategy with Focus on Innovation in Cancer Care
Jarushka Naidoo shared on X: "Special day for Beaumont Hospital as a new 5yr hospital…
Jan 11, 2025, 09:34 | Insight
FDA Released Draft Guidance on Incorporating Tissue Biopsies in Clinical Trials
The U.S. Food and Drug Administration (FDA) issued a draft guidance in collaboration with the…
Jan 11, 2025, 09:29 | Blog
Positive Phase 1 Clinical Data for Emiltatug Ledadotin
Mersana Therapeutics Reported Positive Phase 1 Clinical Data for Emiltatug Ledadotin (XMT-1660) and Expanded Trial…
Jan 11, 2025, 09:26 | Blog
Liver Cancer: One of the Most Preventable Cancers - ELPA
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "Liver Cancer - One…
Jan 11, 2025, 09:17 | Blog
Neoadjuvant Nivo+ Ipi vs ChT in Resectable NSCLC
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Neoadjuvant Nivo+ Ipi vs…
Jan 11, 2025, 09:09 | Blog
Graham faced two cancers back-to-back - prostate and lung - Oncogene Cancer Research
Oncogene Cancer Research shared a post on Instagram: “Graham faced two cancers back-to-back - prostate…
Jan 11, 2025, 09:00 | Opinion
Prostate Cancer Foundation - Interdisciplinary Management of Prostate Cancer
Prostate Cancer Foundation shared on X: "Not all high-risk prostate cancer is the same! Shared…
Jan 11, 2025, 08:55 | Blog
Matthias Guckenberger: Early registration deadline is approaching for ESTRO25
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X: "ESTRO25 in Vienna is…
Jan 11, 2025, 08:49 | Blog
Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared on X:…
All: 93 Posts: 71 - 80
Special Coverage